Enric Monreal

1.0k total citations · 1 hit paper
33 papers, 479 citations indexed

About

Enric Monreal is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Enric Monreal has authored 33 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 16 papers in Neurology and 6 papers in Oncology. Recurrent topics in Enric Monreal's work include Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (7 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Enric Monreal is often cited by papers focused on Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (7 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Enric Monreal collaborates with scholars based in Spain, Canada and Italy. Enric Monreal's co-authors include Jaime Masjuán, Fernando Rodríguez‐Jorge, Juan Luis Chico‐García, Araceli Alonso‐Cánovas, Álvaro Beltrán‐Corbellini, Elena Natera‐Villalba, Juan Carlos Galán, Paloma Parra‐Díaz, J. Porta‐Etessam and Javier Martínez‐Poles and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Enric Monreal

29 papers receiving 466 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study

2020 282 citations Álvaro Beltrán‐Corbellini, Juan Luis Chico‐García et al. European Journal of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enric Monreal Spain	9	271	158	135	115	111	33	479
Fernando Rodríguez‐Jorge Spain	6	226 0.8×	158 1.0×	126 0.9×	36 0.3×	112 1.0×	14	375
Katharina Geißler Germany	13	115 0.4×	64 0.4×	27 0.2×	73 0.6×	49 0.4×	51	474
P Royer France	7	307 1.1×	178 1.1×	250 1.9×	19 0.2×	122 1.1×	46	620
Alberto Vito Marcuzzo Italy	11	118 0.4×	72 0.5×	37 0.3×	10 0.1×	60 0.5×	29	376
Tarek Kashour Saudi Arabia	11	157 0.6×	5 0.0×	159 1.2×	14 0.1×	28 0.3×	19	454
Saad Elzayat Egypt	9	65 0.2×	99 0.6×	28 0.2×	5 0.0×	30 0.3×	58	310
Philomena A. Wawer Matos Germany	8	97 0.4×	63 0.4×	38 0.3×	8 0.1×	43 0.4×	33	249
John Rocke United Kingdom	8	65 0.2×	96 0.6×	33 0.2×	6 0.1×	70 0.6×	17	308
Piergiorgio Gaudioso Italy	8	59 0.2×	77 0.5×	35 0.3×	3 0.0×	42 0.4×	22	207
Yasmeen Senussi United States	4	265 1.0×	9 0.1×	292 2.2×	12 0.1×	11 0.1×	6	455

Countries citing papers authored by Enric Monreal

Since Specialization

Citations

This map shows the geographic impact of Enric Monreal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enric Monreal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enric Monreal more than expected).

Fields of papers citing papers by Enric Monreal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enric Monreal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enric Monreal. The network helps show where Enric Monreal may publish in the future.

Co-authorship network of co-authors of Enric Monreal

This figure shows the co-authorship network connecting the top 25 collaborators of Enric Monreal. A scholar is included among the top collaborators of Enric Monreal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enric Monreal. Enric Monreal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monreal, Enric, Virginia Meca‐Lallana, Ana B. Caminero, et al.. (2025). Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants. Neuropsychiatric Disease and Treatment. Volume 21. 1523–1531.

Domínguez‐Mozo, María Inmaculada, Ignacio Casanova, Enric Monreal, et al.. (2024). Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis. International Journal of Molecular Sciences. 25(18). 10012–10012.

Chico‐García, Juan Luis, Enric Monreal, Susana Sainz de la Maza, et al.. (2024). Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study. Multiple Sclerosis Journal. 30(10). 1341–1349. 1 indexed citations

Monreal, Enric, José Manuel García‐Domínguez, Noelia Villarrubia, et al.. (2024). Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults. International Journal of Molecular Sciences. 25(14). 7808–7808. 3 indexed citations

Monreal, Enric, Juan Luis Chico‐García, Fernando Rodríguez‐Jorge, et al.. (2024). Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients. International Journal of Molecular Sciences. 25(23). 13153–13153. 2 indexed citations

Chico‐García, Juan Luis, Enric Monreal, Fernando Rodríguez‐Jorge, et al.. (2024). Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis. Multiple Sclerosis and Related Disorders. 86. 105595–105595. 3 indexed citations

Monreal, Enric, et al.. (2024). Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis. Frontiers in Public Health. 12. 1397845–1397845. 2 indexed citations

Saposnik, Gustavo, Enric Monreal, Nicolás Medrano, et al.. (2024). Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?. Multiple Sclerosis and Related Disorders. 90. 105838–105838. 2 indexed citations

Monreal, Enric, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.. (2024). Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis. Frontiers in Immunology. 15. 1454474–1454474. 3 indexed citations

10.

Costa‐Frossard, Lucienne, Virginia Meca‐Lallana, Andrés Labiano-Fontcuberta, et al.. (2024). Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study. CNS Drugs. 38(3). 231–238. 3 indexed citations

11.

Maza, Susana Sainz de la, Mario Rodríguez-Domínguez, Enric Monreal, et al.. (2023). Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies. Vaccines. 11(4). 786–786. 1 indexed citations

12.

Chico‐García, Juan Luis, Fernando Rodríguez‐Jorge, Enric Monreal, et al.. (2022). B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab. Multiple Sclerosis and Related Disorders. 68. 104218–104218. 5 indexed citations

13.

Labiano-Fontcuberta, Andrés, Lucienne Costa‐Frossard, Susana Sainz de la Maza, et al.. (2022). The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosis. Multiple Sclerosis and Related Disorders. 64. 103959–103959. 11 indexed citations

14.

Labiano-Fontcuberta, Andrés, Enric Monreal, & Julián Benito‐León. (2022). Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats. Frontiers in Neurology. 13. 995690–995690. 7 indexed citations

15.

López-Sendón, José Luis, et al.. (2021). Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice. Neurología. 39(4). 340–344. 3 indexed citations

16.

Monreal, Enric, Ester Quintana, Susana Sainz de la Maza, et al.. (2021). Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab. Frontiers in Immunology. 12. 760546–760546. 4 indexed citations

17.

Maza, Susana Sainz de la, Noelia Villarrubia, Enric Monreal, et al.. (2021). Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment. Scientific Reports. 11(1). 9299–9299. 10 indexed citations

18.

Beltrán‐Corbellini, Álvaro, Juan Luis Chico‐García, Javier Martínez‐Poles, et al.. (2020). Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study. European Journal of Neurology. 27(9). 1738–1741. 282 indexed citations breakdown →

19.

Pareés, Isabel, José Luis López-Sendón, Enric Monreal, et al.. (2020). COVID-19 in Parkinson’s disease: what holds the key?. Journal of Neurology. 268(8). 2666–2670. 29 indexed citations

20.

Monreal, Enric, Pedro Gullón, Borja M. Fernández‐Félix, et al.. (2019). Increased HIV infection in patients with stroke in Spain. A 16-year population-based study. Enfermedades Infecciosas y Microbiología Clínica. 38(5). 219–225. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact